NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $69.93
Forecasted Upside: 6.19 %
Number of Analysts: 17
Breakdown:
0 Sell Ratings
5 Hold Ratings
12 Buy Ratings
0 Strong Buy Ratings

^$65.85 As of 10/19/2021 02:51 PM ET

▲ +2.88 (4.57%)

1 month | 3 months | 12 months

Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

^$69.93

▲ +6.19% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $69.93, with a high forecast of $88.00 and a low forecast of $36.00. The average price target represents a 6.19% upside from the last price of $65.85.

Current Consensus is Buy

The current consensus among 17 polled investment analysts is to buy stock in Tenet Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
6 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

4/26/2020

0 strong buy ratings
7 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

7/25/2020

0 strong buy ratings
7 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

10/23/2020

0 strong buy ratings
9 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

1/21/2021

0 strong buy ratings
8 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

4/21/2021

0 strong buy ratings
11 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

7/20/2021

0 strong buy ratings
12 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

9/18/2021

0 strong buy ratings
12 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

10/18/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
10/13/2021	Truist Securities	Lower Price Target	Hold	$78.00 ➝ $72.00	Medium
10/13/2021	Truist	Lower Price Target	Hold	$78.00 ➝ $72.00	Low
9/27/2021	SVB Leerink	Initiated Coverage	Market Perform	$80.00	High
9/23/2021	UBS Group	Initiated Coverage	Neutral	$83.00	Medium
9/8/2021	Barclays	Boost Price Target	Overweight	$78.00 ➝ $79.00	Low
8/12/2021	Barclays	Upgrade	Equal Weight ➝ Overweight	$62.00 ➝ $77.00	Medium
8/9/2021	Mizuho	Boost Price Target	Buy	$70.00 ➝ $75.00	Low
7/23/2021	Credit Suisse Group	Boost Price Target	Outperform	$71.00 ➝ $88.00	Medium
7/23/2021	Citigroup	Initiated Coverage	Buy	$70.84	Medium
7/23/2021	Royal Bank of Canada	Boost Price Target	Outperform	$78.00 ➝ $83.00	Medium
7/23/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$69.00 ➝ $80.00	Medium
7/9/2021	Seaport Res Ptn	Reiterated Rating	Buy		Medium
7/9/2021	Seaport Global Securities	Initiated Coverage	Buy	$80.00	High
6/18/2021	Jefferies Financial Group	Reiterated Rating	Buy		High
5/5/2021	Mizuho	Boost Price Target	Buy	$55.00 ➝ $70.00	Low
5/3/2021	The Goldman Sachs Group	Initiated Coverage	Buy		High
4/23/2021	Barclays	Boost Price Target		$55.00 ➝ $62.00	High
4/22/2021	Truist Securities	Boost Price Target		$56.00 ➝ $60.00	Medium
4/22/2021	Truist	Boost Price Target		$56.00 ➝ $60.00	High
4/22/2021	Citigroup	Boost Price Target		$58.00 ➝ $65.00	High
4/22/2021	Credit Suisse Group	Boost Price Target	Outperform	$58.00 ➝ $71.00	High
4/22/2021	Royal Bank of Canada	Boost Price Target	Outperform	$57.00 ➝ $66.00	High
4/9/2021	Mizuho	Boost Price Target	Buy	$48.00 ➝ $55.00	Medium
2/11/2021	Citigroup	Boost Price Target		$50.00 ➝ $58.00	Low
2/11/2021	Credit Suisse Group	Boost Price Target	Outperform	$52.00 ➝ $58.00	Low
1/21/2021	UBS Group	Boost Price Target	Positive ➝ Buy	$37.00 ➝ $60.00	High
1/14/2021	Raymond James	Boost Price Target	Outperform	$55.00 ➝ $60.00	High
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$27.00 ➝ $60.00	Low
1/5/2021	Bank of America	Upgrade	Neutral ➝ Buy	$45.00 ➝ $50.00	N/A
12/18/2020	Mizuho	Boost Price Target	Buy	$32.00 ➝ $48.00	Medium
12/15/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy		Medium
12/11/2020	Smith Barney Citigroup	Boost Price Target		$33.00 ➝ $50.00	High
12/11/2020	Credit Suisse Group	Boost Price Target	Outperform	$39.00 ➝ $48.00	Medium
12/11/2020	Barclays	Boost Price Target	Equal Weight	$28.00 ➝ $46.00	High
11/11/2020	Piper Sandler	Boost Price Target	Neutral	$31.00 ➝ $36.00	High
11/9/2020	Mizuho	Boost Price Target	Buy	$30.00 ➝ $32.00	High
10/22/2020	Raymond James	Boost Price Target	Outperform	$40.00 ➝ $43.00	High
9/21/2020	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$28.00 ➝ $20.00	High
9/4/2020	Royal Bank of Canada	Boost Price Target		$30.00 ➝ $35.00	Low
8/14/2020	Truist	Boost Price Target		$21.00 ➝ $30.00	Medium
8/10/2020	UBS Group	Boost Price Target	Buy	$30.00 ➝ $35.00	Low
8/5/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$25.00 ➝ $28.00	High
8/4/2020	Credit Suisse Group	Reiterated Rating	Buy		High
6/11/2020	UBS Group	Lower Price Target	Buy	$32.00 ➝ $30.00	High
5/29/2020	Mizuho	Lower Price Target	Buy	$32.00 ➝ $30.00	High
5/21/2020	SunTrust Banks	Boost Price Target	Hold	$22.00 ➝ $25.00	Medium
5/20/2020	Citigroup	Lower Price Target	Buy	$35.00 ➝ $27.00	High
5/14/2020	UBS Group	Lower Price Target	Buy	$49.00 ➝ $32.00	High
5/11/2020	Barclays	Boost Price Target	Equal Weight	$19.00 ➝ $22.00	Low
5/6/2020	Credit Suisse Group	Reiterated Rating	Buy	$33.00	Low
5/6/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$40.00 ➝ $32.00	Low
5/6/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$31.00 ➝ $25.00	High
4/13/2020	SunTrust Banks	Boost Price Target	Hold	$18.00 ➝ $22.00	Low
4/13/2020	Royal Bank of Canada	Reiterated Rating	Buy	$26.00	Medium
4/3/2020	SunTrust Banks	Lower Price Target	Hold	$42.00 ➝ $18.00	High
3/25/2020	Barclays	Reiterated Rating	Hold	$19.00	High
3/11/2020	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$32.00 ➝ $39.00	High
2/26/2020	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$31.00 ➝ $32.00	High
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$20.00	Low
12/20/2019	JPMorgan Chase & Co.	Boost Price Target	Underweight	$23.00 ➝ $31.00	Medium
12/18/2019	SunTrust Banks	Boost Price Target	Hold	$31.00 ➝ $42.00	Medium
12/9/2019	UBS Group	Upgrade	Neutral ➝ Buy	$24.00 ➝ $53.00	High
11/7/2019	Mizuho	Reiterated Rating	Buy		Low
11/6/2019	Mizuho	Boost Price Target		$30.00 ➝ $33.00	Low
11/6/2019	SunTrust Banks	Boost Price Target	Hold	$24.00 ➝ $31.00	High
11/6/2019	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$25.00 ➝ $36.00	High
8/14/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$28.00 ➝ $28.00	High
8/11/2019	Royal Bank of Canada	Reiterated Rating	Hold	$26.00	Medium
8/7/2019	SunTrust Banks	Set Price Target	Hold	$24.00	Low
5/1/2019	SunTrust Banks	Lower Price Target	Hold	$27.00	High
4/17/2019	Barclays	Set Price Target	Hold	$24.00	Medium
2/27/2019	Raymond James	Boost Price Target		$37.00 ➝ $47.00	Medium
2/27/2019	Citigroup	Boost Price Target	Buy ➝ Buy	$35.00 ➝ $37.00	High
2/26/2019	Bank of America	Reiterated Rating	Neutral ➝ Neutral	$21.00 ➝ $30.00	High
1/28/2019	Mizuho	Reiterated Rating	Buy	$28.00	Low
1/14/2019	Stephens	Initiated Coverage	Equal ➝ Equal Weight	$23.00	Medium
1/6/2019	Barclays	Reiterated Rating	Hold	$20.00	High
1/3/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold ➝ Hold	$20.00	Low
12/17/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		High
12/3/2018	Raymond James	Reiterated Rating	Buy	$37.00	High
11/15/2018	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$26.00	Low
11/7/2018	Robert W. Baird	Reiterated Rating	Buy	$35.00	High
11/7/2018	Barclays	Reiterated Rating	Hold	$27.00	High
8/14/2018	Barclays	Initiated Coverage	Equal Weight	$35.00	Low
8/10/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight ➝ Underweight	$22.00 ➝ $28.00	Low
8/8/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$34.00	Medium
8/8/2018	SunTrust Banks	Reiterated Rating	Hold	$35.00	Medium
8/7/2018	Mizuho	Set Price Target	Buy	$36.00	Medium
7/23/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$37.00 ➝ $44.00	High
6/29/2018	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$28.00 ➝ $38.00	Medium
5/9/2018	Mizuho	Reiterated Rating	Buy	$35.00	Medium
5/8/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $37.00	Low
5/4/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$27.00 ➝ $33.00	Low
5/2/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$16.00 ➝ $24.00	High
5/2/2018	SVB Leerink	Boost Price Target	Outperform	$30.00 ➝ $40.00	High
4/17/2018	SunTrust Banks	Reiterated Rating	Hold	$27.00	Low
3/22/2018	Mizuho	Reiterated Rating	Buy	$29.00	High
3/5/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight ➝ Underweight	$15.00 ➝ $18.00	Low
3/1/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$21.00	High
3/1/2018	SunTrust Banks	Reiterated Rating	Hold		High
3/1/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $27.00	Low
2/28/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$15.00 ➝ $16.00	Medium
2/28/2018	Wells Fargo & Company	Boost Price Target	Market Perform ➝ Market Perform	$20.00 ➝ $22.00	High
2/28/2018	Raymond James	Upgrade	Market Perform ➝ Outperform	$30.00	High
2/27/2018	Jefferies Financial Group	Set Price Target	Buy	$23.00	Low
1/30/2018	Wells Fargo & Company	Initiated Coverage	Market Perform ➝ Market Perform	$20.00	High
1/3/2018	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$15.00	High
12/20/2017	SVB Leerink	Reiterated Rating	Buy	$27.00	Low
12/20/2017	Morgan Stanley	Downgrade	Equal Weight ➝ Underweight	$14.00	Medium
12/19/2017	Mizuho	Boost Price Target	Neutral	$13.00 ➝ $15.00	High
12/14/2017	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$15.00	Medium
12/12/2017	Citigroup	Upgrade	Neutral ➝ Buy		High
11/21/2017	William Blair	Reiterated Rating	Market Perform		N/A
11/13/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$19.00 ➝ $17.00	N/A
11/10/2017	Mizuho	Reiterated Rating	Neutral ➝ Hold		N/A
11/9/2017	Morgan Stanley	Lower Price Target	Equal Weight	$15.00 ➝ $14.00	N/A
11/8/2017	SVB Leerink	Reiterated Rating	Outperform	$30.00 ➝ $25.00	N/A
11/2/2017	Credit Suisse Group	Initiated Coverage	Neutral	$15.00	N/A
10/30/2017	Jefferies Financial Group	Set Price Target	Buy	$24.00 ➝ $20.00	N/A
10/15/2017	SunTrust Banks	Set Price Target	Hold	$15.00	N/A
9/28/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	High
9/25/2017	Royal Bank of Canada	Reiterated Rating	Hold	$19.00	High
9/21/2017	Jefferies Financial Group	Reiterated Rating	Buy	$24.00	Low
9/14/2017	Mizuho	Reiterated Rating	Neutral	$14.00	Medium
9/14/2017	Citigroup	Reiterated Rating	Hold	$16.00	Medium
9/1/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$24.00	Low
8/24/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	Low
8/24/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	Low
8/20/2017	Mizuho	Reiterated Rating	Neutral	$14.00	High
8/20/2017	SVB Leerink	Reiterated Rating	Outperform	$23.00 ➝ $30.00	High
8/10/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$28.00 ➝ $24.00	Low
8/10/2017	Citigroup	Reiterated Rating	Neutral	$20.00 ➝ $16.00	Medium
8/10/2017	Robert W. Baird	Reiterated Rating	Outperform	$23.00	Medium
8/9/2017	Credit Suisse Group	Lower Price Target	Neutral	$20.00 ➝ $17.00	Low
8/8/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$26.00 ➝ $24.00	High
7/18/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	Medium
6/6/2017	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$27.00	Medium
6/6/2017	Morgan Stanley	Initiated Coverage	Equal ➝ Equal Weight	$19.00	High
6/6/2017	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform	$22.00	Low
5/15/2017	Credit Suisse Group	Boost Price Target	Neutral	$18.00 ➝ $20.00	Medium
5/5/2017	Credit Suisse Group	Boost Price Target	Neutral	$18.00 ➝ $20.00	Low
4/29/2017	Jefferies Financial Group	Reiterated Rating	Buy	$28.00 ➝ $26.00	Low
4/23/2017	Mizuho	Reiterated Rating	Neutral	$18.00	Low
4/13/2017	Jefferies Financial Group	Reiterated Rating	Buy	$28.00	Low
4/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$28.00	High
3/27/2017	Mizuho	Lower Price Target	Neutral	$22.50 ➝ $18.00	High
3/6/2017	Citigroup	Lower Price Target	Neutral	$22.00 ➝ $20.00	N/A
3/3/2017	Royal Bank of Canada	Reiterated Rating	Hold	$25.00	N/A
2/24/2017	Mizuho	Upgrade	Underperform ➝ Neutral	$13.00 ➝ $22.80	N/A
2/6/2017	Jefferies Financial Group	Lower Price Target	Buy	$36.00 ➝ $28.00	N/A
1/24/2017	SVB Leerink	Reiterated Rating	Market Perform	$22.00	N/A
1/11/2017	UBS Group	Reiterated Rating	Buy	$26.00 ➝ $24.00	N/A
1/3/2017	Piper Jaffray Companies	Initiated Coverage	Neutral	$16.00	N/A
11/22/2016	Mizuho	Downgrade	Neutral ➝ Underperform	$13.00	N/A
11/10/2016	Raymond James	Downgrade	Outperform ➝ Market Perform		N/A
11/10/2016	UBS Group	Downgrade	Outperform ➝ Market Perform		N/A
11/9/2016	Bank of America	Downgrade	Buy ➝ Neutral	$32.00 ➝ $25.00	N/A
10/25/2016	Wolfe Research	Initiated Coverage	Market Perform		N/A

(Data available from 10/19/2016 forward)

News Sentiment Rating

0.55 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

0 very positive mentions
2 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/23/2021

0 very positive mentions
1 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/22/2021

0 very positive mentions
3 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

5/22/2021

0 very positive mentions
1 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

6/21/2021

1 very positive mentions
3 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

7/21/2021

6 very positive mentions
10 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

8/20/2021

5 very positive mentions
3 positive mentions
3 negative mentions
2 very negative mentions

Mentions as of

9/19/2021

7 very positive mentions
14 positive mentions
4 negative mentions
0 very negative mentions

Mentions as of

10/19/2021

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Today's Range

Now: $65.85

$63.52

$66.60

50 Day Range

MA: $70.15

$61.02

$75.98

52 Week Range

Now: $65.85

$24.15

$76.15

Volume

34,252 shs

Average Volume

943,016 shs

Market Capitalization

$7.05 billion

P/E Ratio

16.46

Dividend Yield

N/A

Beta

2.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?: The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Mizuho, Piper Sandler, Raymond James, Royal Bank of Canada, Seaport Global Securities, Seaport Res Ptn, Smith Barney Citigroup, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Securities, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for THC.
What is the current price target for Tenet Healthcare?: 16 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $69.93, suggesting a possible upside of 9.9%. Credit Suisse Group AG has the highest price target set, predicting THC will reach $88.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $36.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.
What is the current consensus analyst rating for Tenet Healthcare?: Tenet Healthcare currently has 5 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.
View the latest ratings for THC.
What other companies compete with Tenet Healthcare?: Other companies that are similar to Tenet Healthcare include HCA Healthcare, Alcon, Universal Health Services, Encompass Health, Petco Health and Wellness, Acadia Healthcare, Select Medical, The Ensign Group, Community Health Systems, U.S. Physical Therapy, Brookdale Senior Living, National HealthCare, Five Star Senior Living and Capital Senior Living.
How do I contact Tenet Healthcare's investor relations team?: Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is (469) 893-2200 and its investor relations email address is [email protected] The official website for Tenet Healthcare is www.tenethealth.com.

NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

Analyst Price Target for THC

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.55 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

What is the current price target for Tenet Healthcare?

What is the current consensus analyst rating for Tenet Healthcare?

What other companies compete with Tenet Healthcare?

How do I contact Tenet Healthcare's investor relations team?